For example, stigma and psychosocial stress associated with obesity may play a role, but there are likely many contributors
Triple-receptor agonists or triagonists in development target GLP-1, GIP, and glucagon receptors
Springer International Publishing, 2018
However, there are situations when your body's glutamine needs exceed its capacity to manufacture it
They propose based on rodent and monkey studies that this kind of molecule, when administered at high enough doses, may result in weight loss comparable to the weight loss seen with drugs that include GLP-1 as a target, and without the tolerability issues like nausea and vomiting that often come with the approved treatments, according to a peer-reviewed draft paper published this week
Data were normalized to the geometric average of -actin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and cyclophilin A and reported as fold changes compared to values obtained from the control group (set at 1.0)